VEGFA and hereditary hemorrhagic telangiectasia: In fact, Bevacizumab (Avastin), a humanized monoclonal antibody to VEGF and potent anti-angiogenic drug, has been used to treat HHT patients with severe epistaxis, GI-bleeding, or high-output cardiac failure/hepatic AVMs [83].